Thursday, October 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Wolfram’s Pentagon Pivot: How Almonty Industries Is Rewiring Itself for the US Defense Market

SiterGedge by SiterGedge
April 23, 2026
in Analysis, Commodities, Gold & Precious Metals
0
Almonty Stock
0
SHARES
63
VIEWS
Share on FacebookShare on Twitter

The relocation of a corporate headquarters is rarely a market-moving event. But when Almonty Industries packed up its Toronto office and set up shop in Dillon, Montana — population 4,100 — the message to investors was unmistakable. This tungsten producer is no longer content to be a Canadian mining company with Asian assets. It wants to be an American defense supplier.

Texas Capital took notice. The investment bank upgraded Almonty to “Strong Buy” this week, setting a price target of 43.36 Canadian dollars against a current share price of roughly 28.84 CAD. The rationale hinges on a bet that Almonty’s strategic repositioning will unlock premium valuations tied to US national security spending.

The Montana Connection

The move to Dillon, completed in mid-April, places Almonty within spitting distance of the Gentung-Browns Lake tungsten project it recently acquired. More importantly, it puts the company physically closer to US government agencies and major defense contractors. To cement this shift, Almonty has brought in several retired US military officers to oversee supply chain optimization for defense applications — a move analysts describe as creating a rare “US-first” positioning in the specialty mining space.

Tungsten’s strategic importance has surged. The metal is essential for armor plating, armor-piercing munitions, and advanced electronics. The REEShore Act, which bans Chinese tungsten from US military equipment starting in 2027, has turned a supply concern into a regulatory deadline. Almonty’s western-focused asset base — primarily the Sangdong mine in South Korea and Gentung in Montana — positions it as one of the few credible non-Chinese suppliers.

Sangdong’s Second Act

The operational backbone of Almonty’s growth story remains Sangdong, a mine in South Korea that returned to commercial production in March for the first time in three decades. The Phase 1 ramp-up is complete, with processing capacity hitting roughly 640,000 tonnes of ore per year.

That translates to an expected 2,300 tonnes of tungsten concentrate annually. At full capacity, Sangdong would cover approximately 40% of the world’s tungsten supply outside Chinese control. Management already has plans to double processing capacity next year.

The financials reflect the heavy lifting involved. Fourth-quarter 2025 revenue climbed 39% to 8.72 million Canadian dollars, but the company posted a loss of 0.48 CAD per share. Analysts attribute the deficit to the hefty costs of commissioning major projects and restructuring the business.

Should investors sell immediately? Or is it worth buying Almonty?

A Price Surge That Changes Everything

The macro backdrop has been extraordinarily kind to Almonty. The trailing 12-month average price for tungsten APT has surged 534% to 2,250 USD per MTU. That price explosion is the kind of catalyst that accelerates every timeline and improves every margin projection.

The global tungsten market, estimated at roughly 7.3 billion USD in 2025, is projected to grow to over 11.6 billion USD by 2035. DA Davidson expects Sangdong to reach full commercial ramp-up by the second quarter of 2026.

Almonty funded its expansion through a Nasdaq listing last summer and a subsequent 129-million-USD financing round. The company now trades at roughly 28.84 CAD, with Texas Capital’s cash-flow-based model suggesting significant upside once production phases begin generating free cash flow.

What Comes Next

The next operational milestone is Gentung in Montana, where production is expected to restart before the end of the current calendar year. That project will close the loop on Almonty’s North American supply chain ambitions.

Eight analysts currently recommend buying Almonty shares, with none advising a sale. The company sits at the intersection of multiple demand waves — defense budgets, semiconductor manufacturing, and fusion research — all of which require tungsten in growing quantities.

For a company that just moved its headquarters to a town of 4,100 people, the ambitions are anything but small.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from October 22 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 22.

Almonty: Buy or sell? Read more here...

Tags: Almonty
SiterGedge

SiterGedge

Related Posts

Shell Stock
Commodities

Shell’s Gas Ambitions Meet Buyback Discipline as LNG Canada Talks Take Shape

September 25, 2026
Almonty Stock
Asian Markets

Almonty’s Double Play: A $300 Million Buyback Lands as Sangdong’s Stockpile Grows

September 7, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Next Post
Silber Preis Stock

Silver's Tax Shock: German Rule Change Adds to Geopolitical Headwinds

VINCORION Stock

VINCORION Breaks Through IPO Price as Aftermarket Strength Attracts US Heavyweights

Heidelberger Druckmaschinen Stock

Heidelberger Druck's Strategic Overhaul Faces a Critical Financial Test

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com